Cogent Biosciences, Inc. employees and revenue per employee

COGT · Biotechnology · $5.30B market cap

Cogent Biosciences, Inc. had 15 employees at the end of fiscal Dec 2020, down 79.2% from a year earlier. Revenue for the year was $7.9M, down 65.0% from a year earlier, or $525K per employee. Revenue fell, and headcount fell or held flat with it.

The latest annual report we hold is more than two years old, so these numbers may be out of date.

Employees

15

-79.2% YoY

Revenue

$7.9M

-65.0% YoY

Revenue / employee

$525K

Peer median $546K

Rank in industry

25 of 47

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2018
10129247'18'19'20Revenue 81Staff 27

Hover a year for the numbers.

COGT employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 202015$7.9M$525K-79.2%-65.0%
Dec 201972$22.5M$312K+28.6%+131.1%
Dec 201856$9.7M$174K——

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years
56'1872'1915'20
Revenue per employee, last six fiscal years
$174K'18$312K'19$525K'20

Cogent Biosciences, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
COGT
Cogent Biosciences, Inc.
15$7.9M$525KContracting
KYMR
Kymera Therapeutics, Inc.
238$39.2M$165KHiring into decline
RLAY
Relay Therapeutics, Inc.
192$15.4M$80KLeaner
PRAX
Praxis Precision Medicines, Inc.
116$8.6M$74KEfficient growth
PGEN
Precigen, Inc.
160$9.7M$61KEfficient growth
IMNM
Immunome, Inc.
177$6.9M$39KHiring into decline
CGON
CG Oncology Inc.
142$4.0M$28KEfficient growth
DNTH
Dianthus Therapeutics, Inc.
92$2.0M$22KHiring into decline
CRNX
Crinetics Pharmaceuticals, Inc.
594$7.7M$13KEfficient growth
Every Healthcare company

Questions about Cogent Biosciences, Inc.

How many employees does Cogent Biosciences, Inc. have?
Cogent Biosciences, Inc. reported 15 employees for the fiscal year ending Dec 2020, in the annual report it filed on March 16, 2021. That is down 79.2% from a year earlier.
What is Cogent Biosciences, Inc.'s revenue per employee?
Cogent Biosciences, Inc. brought in $7.9M of revenue in fiscal Dec 2020, which is $525K per employee. That ranks 25 of 47 companies we track in Biotechnology, where the median is $546K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare COGT with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Cogent Biosciences, Inc.'s annual reports (Form 10-K), latest filed March 16, 2021. This is data, not a recommendation to buy or sell COGT.